FR2680687B1 - - Google Patents

Info

Publication number
FR2680687B1
FR2680687B1 FR9110899A FR9110899A FR2680687B1 FR 2680687 B1 FR2680687 B1 FR 2680687B1 FR 9110899 A FR9110899 A FR 9110899A FR 9110899 A FR9110899 A FR 9110899A FR 2680687 B1 FR2680687 B1 FR 2680687B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9110899A
Other languages
French (fr)
Other versions
FR2680687A1 (fr
Inventor
Marie-Christine Etienne
Generaliste Medecin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9110899A priority Critical patent/FR2680687A1/fr
Priority to CA002142863A priority patent/CA2142863A1/fr
Priority to DE69223811T priority patent/DE69223811T2/de
Priority to PCT/FR1992/000813 priority patent/WO1994004186A1/fr
Priority to AU25105/92A priority patent/AU2510592A/en
Priority to EP92918959A priority patent/EP0655928B1/fr
Publication of FR2680687A1 publication Critical patent/FR2680687A1/fr
Application granted granted Critical
Publication of FR2680687B1 publication Critical patent/FR2680687B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9110899A 1991-08-29 1991-08-29 Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales. Granted FR2680687A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9110899A FR2680687A1 (fr) 1991-08-29 1991-08-29 Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.
CA002142863A CA2142863A1 (fr) 1991-08-29 1992-08-21 Compositions homeopathiques pour le traitement des maladies virales et metaboliques
DE69223811T DE69223811T2 (de) 1991-08-29 1992-08-21 Verwendung eines homöopathisches Erzeugnisses zur Herstellung eines Arzneimittels für die Behandlung von metabolischen Krankheiten
PCT/FR1992/000813 WO1994004186A1 (fr) 1991-08-29 1992-08-21 Compositions homeopathiques pour le traitement des maladies virales et metaboliques
AU25105/92A AU2510592A (en) 1991-08-29 1992-08-21 Homeopathic compositions for the treatment of viral and metabolic diseases
EP92918959A EP0655928B1 (fr) 1991-08-29 1992-08-21 Utilisation d'un produit homéopathique pour la préparation d'un médicament destiné au traitement de maladies métaboliques

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9110899A FR2680687A1 (fr) 1991-08-29 1991-08-29 Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.
CA002142863A CA2142863A1 (fr) 1991-08-29 1992-08-21 Compositions homeopathiques pour le traitement des maladies virales et metaboliques
PCT/FR1992/000813 WO1994004186A1 (fr) 1991-08-29 1992-08-21 Compositions homeopathiques pour le traitement des maladies virales et metaboliques

Publications (2)

Publication Number Publication Date
FR2680687A1 FR2680687A1 (fr) 1993-03-05
FR2680687B1 true FR2680687B1 (uk) 1995-03-24

Family

ID=27169961

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9110899A Granted FR2680687A1 (fr) 1991-08-29 1991-08-29 Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.

Country Status (3)

Country Link
CA (1) CA2142863A1 (uk)
FR (1) FR2680687A1 (uk)
WO (1) WO1994004186A1 (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713487B1 (fr) * 1993-12-09 1996-02-02 Labo Life Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène.
GB9426409D0 (en) * 1994-12-30 1995-03-01 Britannia Health Products Ltd A composition for treating endometriosis
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
CA2293808C (en) 1997-06-13 2006-10-17 Progenitor, Inc. Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
WO2011143609A1 (en) * 2010-05-14 2011-11-17 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624013B2 (fr) * 1987-10-08 1991-07-12 Medibrevex Application comme medicaments utiles pour le traitement allopathique des maladies allergiques de formes galeniques d'oeufs de caille

Also Published As

Publication number Publication date
WO1994004186A1 (fr) 1994-03-03
CA2142863A1 (fr) 1994-03-03
FR2680687A1 (fr) 1993-03-05

Similar Documents

Publication Publication Date Title
DK0616505T3 (uk)
EP0531653A3 (uk)
EP0539116A3 (uk)
DE4290659T1 (uk)
EP0535696A3 (uk)
EP0527469A3 (uk)
EP0534777A3 (uk)
EP0503606A3 (uk)
FR2676353B1 (uk)
DE4290190T1 (uk)
FR2674176B1 (uk)
FR2674288B1 (uk)
FR2677254B1 (uk)
FR2675000B1 (uk)
FR2677119B1 (uk)
FR2674583B1 (uk)
FR2675750B1 (uk)
FR2677334B1 (uk)
FR2671715B1 (uk)
FR2672342B1 (uk)
EP0538812A3 (uk)
EP0550128A3 (uk)
EP0535490A3 (uk)
EP0535630A3 (uk)
EP0534463A3 (uk)